Meeting
2014 ASCO Annual Meeting
Predictive markers for clinical outcome after neoadjuvant radiochemotherapy in breast cancer patients.
Authors
Christiane Matuschek
University of Düsseldorf, Düsseldorf, Germany
Christiane Matuschek , Edwin Boelke , Hans Bojar , Werner Audretsch , Hans Bernd Prisack , Wilfried Budach , Carolin Nestle-Kraemling
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Immunotherapy
Track
Developmental Therapeutics
Sub Track
Biomarkers and Correlative Studies from Immunotherapy Trials
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3041)
DOI
10.1200/jco.2014.32.15_suppl.3041
Abstract #
3041
Poster Bd #
108
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The proliferation biomarker SPAG5 expression in HER2 low and HER2 overexpression early breast cancer (BC) predicting tumour response to neoadjuvant chemotherapy (NACT) with and without trastuzumab.
First Author: Tarek Mohamed Ahmed Abdel-Fatah
Poster
2019 ASCO Annual Meeting
Correlation between mutation landscape and clinical outcomes of neoadjuvant therapy in HER2-positive breast cancer patients.
First Author: Ning Liao
Poster
2014 ASCO Annual Meeting
Molecular profiling of resected esophageal cancer and its correlation with clinical outcome.
First Author: Tomoya Yokota
Poster
2013 Breast Cancer Symposium
Biomarkers predictive for pathologic response to neoadjuvant docetaxel/cyclophosphamide chemotherapy in primary breast cancer.
First Author: Kazuhiro Shimada